Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook

Index by Author

September/October 2016; Volume 70,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Bakhshayeshi, Meisam

    1. You have access
      Session 4.1: Case Studies of Application of Generic Claims and QbD for Viral Clearance
      Rachel Specht and Meisam Bakhshayeshi
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 462-469; DOI: https://doi.org/10.5731/pdajpst.2016.006957
    2. You have access
      Session 4.2: Viral Spiking, Viral Preparation, and Upstream Risk Mitigation Strategies
      Meisam Bakhshayeshi and Rachel Specht
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 470-476; DOI: https://doi.org/10.5731/pdajpst.2016.006965
  2. Blümel, Johannes

    1. You have access
      Session 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
      Glen Bolton and Johannes Blümel
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 477-481; DOI: https://doi.org/10.5731/pdajpst.2016.006973
    2. You have access
      Session 2: Company-Specific Data on Cycled Resin Testing
      Johannes Blümel and Kurt Brorson
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 428-442; DOI: https://doi.org/10.5731/pdajpst.2016.006924
  3. Bolton, Glen

    1. You have access
      Session 5: Conference Summary: Key Discussion and Outcomes, Pending Questions, and Proposed Experiments
      Glen Bolton and Johannes Blümel
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 477-481; DOI: https://doi.org/10.5731/pdajpst.2016.006973
    2. You have access
      Introduction: Proceedings of the 2015 Viral Clearance Symposium
      Glen Bolton and Rich Levy
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 409; DOI: https://doi.org/10.5731/pdajpst.2016.006874
  4. Brorson, Kurt

    1. You have access
      Session 2: Company-Specific Data on Cycled Resin Testing
      Johannes Blümel and Kurt Brorson
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 428-442; DOI: https://doi.org/10.5731/pdajpst.2016.006924
  5. Buhlmann, Bob

    1. You have access
      PDA Points To Consider: Fundamental Concepts in Data Integrity
      Bob Buhlmann, Madlene Dole and Zena Kaufmann
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 482-488; DOI: https://doi.org/10.5731/pdajpst.2016.007062

C

  1. Chen, Dayue

    1. You have access
      Session 3.1: Protein A, Hydroxyapatite, and Mixed-Mode Chromatography
      Dayue Chen
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 443-450; DOI: https://doi.org/10.5731/pdajpst.2016.006932

D

  1. Dole, Madlene

    1. You have access
      PDA Points To Consider: Fundamental Concepts in Data Integrity
      Bob Buhlmann, Madlene Dole and Zena Kaufmann
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 482-488; DOI: https://doi.org/10.5731/pdajpst.2016.007062

G

  1. Gallo, Christopher

    1. You have access
      Session 3.2: Viral Clearance of Emerging Unit Operations: Membrane Chromatography, Other Methods, Etc.
      Christopher Gallo
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 451-461; DOI: https://doi.org/10.5731/pdajpst.2016.006940

K

  1. Kaufmann, Zena

    1. You have access
      PDA Points To Consider: Fundamental Concepts in Data Integrity
      Bob Buhlmann, Madlene Dole and Zena Kaufmann
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 482-488; DOI: https://doi.org/10.5731/pdajpst.2016.007062

L

  1. Levy, Rich

    1. You have access
      Introduction: Proceedings of the 2015 Viral Clearance Symposium
      Glen Bolton and Rich Levy
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 409; DOI: https://doi.org/10.5731/pdajpst.2016.006874

M

  1. Ma, Junfen

    1. You have access
      Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation
      Junfen Ma and David Roush
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 410-416; DOI: https://doi.org/10.5731/pdajpst.2016.006890
    2. You have access
      Viral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive Filtration
      David Roush and Junfen Ma
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 417-427; DOI: https://doi.org/10.5731/pdajpst.2016.006916

R

  1. Roush, David

    1. You have access
      Session 1.1: Viral Clearance Using Traditional, Well-Understood Unit Operations: Low pH and Detergent Viral Inactivation
      Junfen Ma and David Roush
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 410-416; DOI: https://doi.org/10.5731/pdajpst.2016.006890
    2. You have access
      Viral Clearance Using Traditional, Well-Understood Unit Operations Session 1.2: Virus-Retentive Filtration
      David Roush and Junfen Ma
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 417-427; DOI: https://doi.org/10.5731/pdajpst.2016.006916

S

  1. Specht, Rachel

    1. You have access
      Session 4.1: Case Studies of Application of Generic Claims and QbD for Viral Clearance
      Rachel Specht and Meisam Bakhshayeshi
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 462-469; DOI: https://doi.org/10.5731/pdajpst.2016.006957
    2. You have access
      Session 4.2: Viral Spiking, Viral Preparation, and Upstream Risk Mitigation Strategies
      Meisam Bakhshayeshi and Rachel Specht
      PDA Journal of Pharmaceutical Science and Technology September 2016, 70 (5) 470-476; DOI: https://doi.org/10.5731/pdajpst.2016.006965
Back to top
PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 70 (5)
PDA Journal of Pharmaceutical Science and Technology
Vol. 70, Issue 5
September/October 2016
  • Table of Contents
  • Index by Author
Sign up for Alerts

  • Most Cited
  • Most Read
Loading
  • A New Integrated Modeling Approach with Case Studies for Gas Transmission of Container Closure Headspace
  • A Commentary on Several Study Design Considerations Pertaining to the Screening of Substances Extracted and/or Leached from Pharmaceutical Contact Materials
  • Low-Volume Aseptic Filling Using a Linear Peristaltic Pump
  • The Implications of Chromatographically Screening Medical Products for Organic Leachables Down to the Analytical Evaluation Threshold Adjusted for Response Factor Variation
More...

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2023 PDA Journal of Pharmaceutical Science and Technology ISSN: 1079-7440

Powered by HighWire